MacroGenics
MGNX
MGNX
133 hedge funds and large institutions have $467M invested in MacroGenics in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 36 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
41% less capital invested
Capital invested by funds: $789M → $467M (-$322M)
78% less call options, than puts
Call options by funds: $17K | Put options by funds: $79K
Holders
133
Holding in Top 10
3
Calls
$17K
Puts
$79K
Top Buyers
| 1 | +$4.56M | |
| 2 | +$4.35M | |
| 3 | +$4.23M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$3.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.56M |
Top Sellers
| 1 | -$31.8M | |
| 2 | -$9.25M | |
| 3 | -$8.32M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.22M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.08M |